Hoffman Koen 4

What Happened
Koen Hoffman, a director of MDxHealth SA (MDXH), received a grant of options to purchase 10,000 ordinary shares on June 1, 2026. The Form 4 reports the acquisition as a derivative grant (acquisition price listed as $0.00); the options have a $0.76 exercise price per share (see footnote). This is an award/compensation-related grant, not an open-market purchase or sale.

Key Details

• Transaction date: June 1, 2026; Form 4 filed June 3, 2026 (appears timely).
• Instrument: Options to purchase 10,000 ordinary shares; acquisition amount shown as $0.00 on the Form 4.
• Exercise price: $0.76 per share (footnote F1).
• Vesting: Options vest in full on the date of the annual general shareholders’ meeting in the calendar year following the year of grant (i.e., the AGM in 2027 for a June 1, 2026 grant) (footnote F1).
• Shares/options owned after transaction: Not disclosed in this Form 4.
• Ownership note: Footnote F2 states share options held by Ahok BV may be deemed beneficially owned by the reporting person because he owns 53.33% of Ahok BV; he disclaims beneficial ownership except to the extent of any pecuniary interest.
• Filing timeliness: No late-filing flag indicated in the provided data.

Context
This was an equity-compensation grant (options) rather than a market trade. The options give the right to buy shares at $0.76 in the future subject to vesting; they were not exercised or sold at the time of the filing. Such grants are commonly used for director compensation and retention and do not by themselves indicate immediate insider buying or selling of stock.